Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study).
Pina, Liza Miriam MD a; Dong, Xiangwen PhD a; Zhang, Liping PhD a; Samtani, Mahesh N. PhD a; Michelson, Alan D. MD b; Justino, Henri MD c; Bonnet, Damien MD d; Harris, Kevin C. MD e; Jefferies, John MD f; McCrindle, Brian W. MD g; Li, Jennifer S. MD h,*
American Heart Journal.
213:97-104, July 2019.
(Format: HTML, PDF)